Abstract

Evidence-based guidelines have undergone an incredible transformation over the last number of years. Significant advances include explicit linkages of systematic evidence summaries to the strength and direction of recommendations, consideration of all patient-important factors, transparent reporting of the recommendation generation process including conflict of interest management strategies and the production of clinical practice guidelines which use simple and clear language. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology provides a framework for guideline development and was employed to produce the recently published ATS/ERS/JRS/ALAT update on treatment for idiopathic pulmonary fibrosis (IPF). Herein we discuss the advantages of using an evidence-based approach for guideline development using the IPF process and resultant document as an example.

Highlights

  • Evidence-based guidelines have undergone intense evolution over the last 15 years [1,2,3,4]

  • This distinction represents a typical misunderstanding as even in the era of evidence-based guidelines, recommendations are developed by clinical experts in the field and require consensus of panel members on the best possible treatment options

  • It is the transparent link between the evidence and the recommendations and the requirement of making structured expert judgments that represents a shift in the guideline development paradigm

Read more

Summary

Introduction

Evidence-based guidelines have undergone intense evolution over the last 15 years [1,2,3,4]. This distinction represents a typical misunderstanding as even in the era of evidence-based guidelines, recommendations are developed by clinical experts in the field and require consensus of panel members on the best possible treatment options.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call